TrialJournal of diabetes investigation2025

Effect of administration and withdrawal of the sodium-glucose cotransporter 2 inhibitor, tofogliflozin, on renal protection in individuals with type 2 diabetes mellitus and diabetic nephropathy: A multicenter, single-arm study (RESTORE-nephropathy study).

Ayako Shigeta et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.